发明名称 SUSTAINED-RELEASE LOCAL DRUG DELIVERY SYSTEM COMPRISING FIBRINOGEN, APROTININ, LIDOCAINE, EPINEPHRINE, AND COLLAGEN MEMBRANE, AND COMPOSITION FOR TREATING OSTEOPATHIA USING THE SAME
摘要 <p>The present invention relates to a sustained-release local drug delivery system including fibrinogen, aprotinin, lidocaine, epinephrine, and collagen membrane, a kit, and a composition for treating osteopathia using the same. The sustained-release local drug delivery system according to the present invention can exhibit continuous pharmaceutically active effects with a small quantity by means of excellent sustained-release effects and excellently show biocompatibility including the promotion of revasculariation and new bone formation, so as to be usefully used as a sustained-release local drug delivery system for a pharmaceutically active material which needs to discharge drugs continuously for a long time and be usefully used to treat various diseases generated by incomplete osteogenesis by applying BMP to the local drug delivery system.</p>
申请公布号 KR20140090481(A) 申请公布日期 2014.07.17
申请号 KR20130002592 申请日期 2013.01.09
申请人 WONKWANG UNIVERSITY CENTER FOR INDUSTRY-ACADEMY COOPERATION 发明人 KWON, KYUNG HWAN
分类号 A61K9/08;A61K31/137;A61K31/167;A61K38/36 主分类号 A61K9/08
代理机构 代理人
主权项
地址